It is generally accepted that neoplastic transformation is related to
genes alteration or oncogene activation. In particular,DNA minor groov
e binding drugs have been extensively studied through the years in ord
er to influence the regulation of gene expression by means of specific
interactions with DNA bases moieties. Pyrrolo[2,1-c].[l,il].benzodiaz
epine (PBDs), CC-1065 and distamycins are three classes of minor groov
e binders which showed interesting cytotoxicity profiles, refined thro
ugh already reviewed processes of SAR studies. Among the modifications
to the three families of antitumor compounds, hererocyclic substituti
ons have been extensively applied by many groups in order to either mo
dify the reactivity profile or introduce extra interactions within the
minor groove, thus changing the binding site or modulating the bindin
g sequence. The updated material related to these modifications has be
en rationalised and ordered in order to offer an overview of the argum
ent.